Kansas biologics regulations.

Who may administer PRP, exosomes and stem cells in Kansas, and which agencies to check.

A physician at a desk reading regulatory documents

Who may administer biologics in Kansas?

In Kansas, only licensed medical professionals such as MDs, DOs, and APRNs with appropriate training are typically permitted to administer biologic therapies. For those interested in becoming certified, understanding Kansas’s licensing requirements will help ensure your eligibility to administer biologic products.

Official sources

Kansas compliance guide.

FDA Compliance

The FDA regulates biologics under the Public Health Service (PHS) Act and 21 CFR Part 1271, particularly under the Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/P) regulations. The FDA classifies certain biologic products based on manipulation, intended use, and homologous function. Products that do not meet the FDA’s minimal manipulation or homologous use criteria generally require an approved Biologics License Application (BLA).

Kansas providers should ensure they comply with these federal guidelines, especially if they intend to use products not meeting the “361 HCT/P” criteria, which exempts them from full FDA premarket approval. Clinics should also review updates on the FDA’s Biologics page for any changes in regulations.

Kansas State Regulations

The Kansas Department of Health and Environment (KDHE) governs state health regulations. While Kansas does not have unique rules for biologics, general medical practice regulations apply. Clinics offering biologics can refer to KDHE’s official website for guidance on meeting state compliance standards. Practitioners should understand that adherence to Kansas regulations alongside FDA guidelines is key to accessible and thorough compliance.

Provider Qualifications

In Kansas, only licensed medical professionals such as MDs, DOs, and APRNs with appropriate training are typically permitted to administer biologic therapies. Providers must have valid credentials from the Kansas State Board of Healing Arts. For those interested in becoming certified, understanding Kansas’s licensing requirements will help ensure your eligibility to administer biologic products.

Patient Informed Consent

Patient consent is critical in biologics. Kansas clinics should obtain detailed, signed consent forms that disclose:

  • The risks, benefits, and potential side effects of the treatment
  • The experimental or unapproved nature of some biologic therapies
  • Alternative treatment options and the option to withdraw at any time. Ensuring patients are fully informed reduces legal risks and aligns with best practices in patient care.

Additional Compliance Considerations

Pre-Treatment and Post-Treatment Protocols

Documented protocols for pre-treatment screening and post-treatment follow-up are recommended. These can help maintain patient safety and ensure ongoing compliance. Providers should establish and train staff on these protocols to reduce risks and improve treatment outcomes.

Standard Operating Procedures (SOPs)

Developing SOPs specific to biologic handling, storage, and administration can further ensure compliance. SOPs should align with both FDA and Kansas requirements to maintain the highest standards of care and consistency in patient treatment.

Medical Liability Insurance

Kansas practitioners should verify that their liability insurance covers biologics. Specialized coverage may be necessary, especially for providers offering investigational treatments.

Marketing Compliance

Marketing claims must align with FDA and Kansas regulations. Avoid promises of specific outcomes and disclose the experimental status of certain therapies. Advertising materials should be reviewed by legal or compliance experts to ensure adherence to all applicable guidelines.

This guide is a general summary to help clinics understand compliance requirements for biologics in Kansas. It is not legal advice. Regulations change; consult legal counsel and the agencies above before acting on it.

Kansas: common questions.

Who can administer stem cells, PRP and exosomes in Kansas?
In Kansas, only licensed medical professionals such as MDs, DOs, and APRNs with appropriate training are typically permitted to administer biologic therapies. For those interested in becoming certified, understanding Kansas’s licensing requirements will help ensure your eligibility to administer biologic products. This is a general summary, not legal advice. Confirm with the state board.
Are stem cell and exosome therapies FDA-approved in Kansas?
FDA rules are federal, so they apply in Kansas as everywhere else. Exosome and stem cell therapies are not FDA-approved for therapeutic use, and PRP applications are considered off-label.
Do I need an IRB-approved study to offer biologics in Kansas?
Investigational treatment belongs inside a reviewed study with proper informed consent. IRB review is not FDA authorisation: culture-expanded and other more-than-minimally-manipulated cell products generally need an IND before use in people.
How do I start offering biologics in Kansas?
Start with the live webinar, then a discovery call and live training. After that we verify your Kansas licence, protocol, product sourcing, consent process and advertising before you are listed for patient inquiries.

Practising in Kansas? Start with the webinar.

Live on Zoom, Tuesdays at 12:00 PM ET. See how the model works before you commit to anything.